CBD and CBG isolate and distillate API products offer distinct advantages depending on their intended applications in pharmaceutical development, product formulation, and broader manufacturing contexts.
CBD & CBG Isolate and Distillate API Products
Pharmaceutical Grade CBD Isolate API (DMF, PIC/S)
Suited for pharmaceutical R&D and drug development. Its consistent molecular profile minimizes the risk of batch variability, a critical consideration for regulatory filings. Vantage Hemp’s Pharmaceutical Grade CBD Isolate is registered under Drug Master File #037784
EP Compliant CBD Isolate API (cGMP)
Batch VH240043 meets all critical specifications for purity, identity, impurities, and safety, under the European Pharmacopoeia CBD monograph, ensuring it is suitable for medicinal applications in the EU market.
TGO93 THC-Free CBD Distillate API (PIC/S)
THC-free Distillate API is internationally certified PIC/S by the Therapeutic Goods Administration of Australia. Ideal for use in restrictive THC markets where a versatile distillate is required.
Pharmaceutical Grade CBG Isolate API (cGMP)
CBG, often referred to as the “mother cannabinoid,” is the precursor from which other cannabinoids, such as THC, CBD, and CBN, are derived.
White Paper: The Science of CBD from Extraction to Wellness
